Literature DB >> 24478383

Tie2 and Eph receptor tyrosine kinase activation and signaling.

William A Barton1, Annamarie C Dalton, Tom C M Seegar, Juha P Himanen, Dimitar B Nikolov.   

Abstract

The Eph and Tie cell surface receptors mediate a variety of signaling events during development and in the adult organism. As other receptor tyrosine kinases, they are activated on binding of extracellular ligands and their catalytic activity is tightly regulated on multiple levels. The Eph and Tie receptors display some unique characteristics, including the requirement of ligand-induced receptor clustering for efficient signaling. Interestingly, both Ephs and Ties can mediate different, even opposite, biological effects depending on the specific ligand eliciting the response and on the cellular context. Here we discuss the structural features of these receptors, their interactions with various ligands, as well as functional implications for downstream signaling initiation. The Eph/ephrin structures are already well reviewed and we only provide a brief overview on the initial binding events. We go into more detail discussing the Tie-angiopoietin structures and recognition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24478383      PMCID: PMC3949358          DOI: 10.1101/cshperspect.a009142

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  105 in total

Review 1.  Excitatory Eph receptors and adhesive ephrin ligands.

Authors:  R Klein
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

2.  Cancer cells exploit the Eph-ephrin system to promote invasion and metastasis: tales of unwitting partners.

Authors:  Bingcheng Wang
Journal:  Sci Signal       Date:  2011-05-31       Impact factor: 8.192

Review 3.  Receptor tyrosine kinase transmembrane domains: Function, dimer structure and dimerization energetics.

Authors:  Edwin Li; Kalina Hristova
Journal:  Cell Adh Migr       Date:  2010-04-23       Impact factor: 3.405

4.  Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans.

Authors:  Peter W Janes; Nayanendu Saha; William A Barton; Momchil V Kolev; Sabine H Wimmer-Kleikamp; Eva Nievergall; Carl P Blobel; Juha-Pekka Himanen; Martin Lackmann; Dimitar B Nikolov
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

5.  A tyrosine kinase profile of prostate carcinoma.

Authors:  D Robinson; F He; T Pretlow; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

6.  Autoregulation by the juxtamembrane region of the human ephrin receptor tyrosine kinase A3 (EphA3).

Authors:  Tara L Davis; John R Walker; Peter Loppnau; Christine Butler-Cole; Abdellah Allali-Hassani; Sirano Dhe-Paganon
Journal:  Structure       Date:  2008-06       Impact factor: 5.006

Review 7.  Eph receptor signaling and ephrins.

Authors:  Erika M Lisabeth; Giulia Falivelli; Elena B Pasquale
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

8.  The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals.

Authors:  C A Cowan; M Henkemeyer
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

Review 9.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

10.  A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo.

Authors:  Aaron Petty; Eugene Myshkin; Haina Qin; Hong Guo; Hui Miao; Gregory P Tochtrop; Jer-Tsong Hsieh; Phillip Page; Lili Liu; Daniel J Lindner; Chayan Acharya; Alexander D MacKerell; Eckhard Ficker; Jianxing Song; Bingcheng Wang
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

View more
  12 in total

Review 1.  Eph receptor signaling and ephrins.

Authors:  Erika M Lisabeth; Giulia Falivelli; Elena B Pasquale
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

2.  Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.

Authors:  Tomokazu Souma; Stuart W Tompson; Benjamin R Thomson; Owen M Siggs; Krishnakumar Kizhatil; Shinji Yamaguchi; Liang Feng; Vachiranee Limviphuvadh; Kristina N Whisenhunt; Sebastian Maurer-Stroh; Tammy L Yanovitch; Luba Kalaydjieva; Dimitar N Azmanov; Simone Finzi; Lucia Mauri; Shahrbanou Javadiyan; Emmanuelle Souzeau; Tiger Zhou; Alex W Hewitt; Bethany Kloss; Kathryn P Burdon; David A Mackey; Keri F Allen; Jonathan B Ruddle; Sing-Hui Lim; Steve Rozen; Khanh-Nhat Tran-Viet; Xiaorong Liu; Simon John; Janey L Wiggs; Francesca Pasutto; Jamie E Craig; Jing Jin; Susan E Quaggin; Terri L Young
Journal:  J Clin Invest       Date:  2016-06-06       Impact factor: 14.808

3.  Dimerization of Tie2 mediated by its membrane-proximal FNIII domains.

Authors:  Jason O Moore; Mark A Lemmon; Kathryn M Ferguson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

4.  Effects of sleeve gastrectomy and rs9930506 FTO variants on angiopoietin/Tie-2 system in fat expansion and M1 macrophages recruitment in morbidly obese subjects.

Authors:  Nicté Figueroa-Vega; Benjamín Jordán; Elva Leticia Pérez-Luque; Luis Parra-Laporte; Serafín Garnelo; Juan Manuel Malacara
Journal:  Endocrine       Date:  2016-08-31       Impact factor: 3.633

Review 5.  Mechanistic insights into the role of FOXO in diabetic retinopathy.

Authors:  Tapan Behl; Muskan Wadhwa; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Saurabh Bhatia; Ahmed Al-Harrasi; Lotfi Aleya; Simona Bungau
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

6.  Angiopoietin-1 is required for Schlemm's canal development in mice and humans.

Authors:  Benjamin R Thomson; Tomokazu Souma; Stuart W Tompson; Tuncer Onay; Krishnakumar Kizhatil; Owen M Siggs; Liang Feng; Kristina N Whisenhunt; Tammy L Yanovitch; Luba Kalaydjieva; Dimitar N Azmanov; Simone Finzi; Christine E Tanna; Alex W Hewitt; David A Mackey; Yasmin S Bradfield; Emmanuelle Souzeau; Shari Javadiyan; Janey L Wiggs; Francesca Pasutto; Xiaorong Liu; Simon Wm John; Jamie E Craig; Jing Jin; Terri L Young; Susan E Quaggin
Journal:  J Clin Invest       Date:  2017-11-06       Impact factor: 14.808

Review 7.  Structure-function relationships of ErbB RTKs in the plasma membrane of living cells.

Authors:  Donna J Arndt-Jovin; Michelle G Botelho; Thomas M Jovin
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-04-01       Impact factor: 10.005

Review 8.  Antiangiogenic Effect of Alkaloids.

Authors:  Masoud Alasvand; Vahideh Assadollahi; Roberto Ambra; Ehsan Hedayati; Wesam Kooti; Ilaria Peluso
Journal:  Oxid Med Cell Longev       Date:  2019-04-21       Impact factor: 6.543

9.  Stage-dependent angiopoietin-Tie2 and nitric oxide signaling of erythrocytes in response to surgical trauma in head and neck cancer.

Authors:  Hsiang-Ling Wu; You-Hsiang Chu; Ying-Hsuan Tai; Mei-Yung Tsou; Cheng-Hsien Wu; Wen-Liang Lo; Shyh-Kuan Tai; Chun-Chang Yeh; Chih-Cherng Lu
Journal:  World J Surg Oncol       Date:  2020-08-16       Impact factor: 2.754

10.  SVEP1 as a Genetic Modifier of TEK-Related Primary Congenital Glaucoma.

Authors:  Terri L Young; Kristina N Whisenhunt; Jing Jin; Sarah M LaMartina; Sean M Martin; Tomokazu Souma; Vachiranee Limviphuvadh; Fatemeh Suri; Emmanuelle Souzeau; Xue Zhang; Yongwook Dan; Evie Anagnos; Susana Carmona; Nicole M Jody; Nickie Stangel; Emily C Higuchi; Samuel J Huang; Owen M Siggs; Maria José Simões; Brendan M Lawson; Jacob S Martin; Elahe Elahi; Mehrnaz Narooie-Nejad; Behzad Fallahi Motlagh; Susan E Quaggin; Heather D Potter; Eduardo D Silva; Jamie E Craig; Conceição Egas; Reza Maroofian; Sebastian Maurer-Stroh; Yasmin S Bradfield; Stuart W Tompson
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-10-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.